• Developed chemotherapeutic nanoparticles (mucus penetrating particles MPP) that can overcome human mucus barriers and effectively suppress the growth of cervical tumors • Optimized nanoparticles (NP) formulation for improved drug loading and physical-chemical properties • Experimental design and data analysis for evaluate the anti-tumor effects of chemotherapeutic nanoparticles • Our results have shown that our new platform is significantly more effective than conventional drug delivery systems • A manuscript is being prepared based on our discovery